ArticleNature machine intelligence2026
Reusability Report: Evaluating the performance of a meta-learning foundation model on predicting the antibacterial activity of natural products.
Article in Nature machine intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Improving Generalizability in Whole-Cell Antibiotic Discovery Through Active Learning.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
- Update of
Authors and funding
2 authors.
Funding
Abstract
Deep learning foundation models are becoming increasingly popular for use in bioactivity prediction. Recently, Feng et al. developed ActFound, a bioactive foundation model that jointly uses pairwise learning and meta-learning. By utilizing these techniques, the model is capable of being fine-tuned to a more specific bioactivity task with only a small amount of new data. Here, to investigate the generalizability of the model, we looked to fine-tune the foundation model on an antibacterial natural products (NPs) dataset. Large, labelled NPs datasets, which are needed to train traditional deep learning methods, are scarce. Therefore, the bioactivity prediction of NPs is an ideal task for foundation models. We studied the performance of ActFound on the NPs dataset using a range of few-shot settings. Additionally, we compared ActFound's performance with those of other state-of-the-art models in the field. We found ActFound was unable to reach the same level of accuracy on the antibacterial NPs dataset as it did on other cross-domain tasks reported in the original publication. However, ActFound displayed comparable or better performance compared to the other models studied, especially at the low-shot settings. Our results establish ActFound as a useful foundation model for the bioactivity prediction of tasks with limited data, particularly for datasets that contain the bioactivities of similar compounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.